Memorial Sloan Kettering Cancer Center

Malignant Bone-Forming Neoplasm With NIPBL::BEND2 Fusion (2024) Dashti NK, Matcuk G, Agaimy A, Saoud C, Antonescu CR Journal article Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials (2024) Fokas E, Williams H, Diefenhardt M, Lin S, Qin LX, Piso P, Dapper H, et al. Journal article Reconstructing extrachromosomal DNA structural heterogeneity from long-read sequencing data using Decoil (2024) Giurgiu M, Wittstruck N, Rodriguez-Fos E, González RC, Brückner L, Krienelke-Szymansky A, Helmsauer K, et al. Journal article TFE3 -Rearranged PEComa/PEComa-like Neoplasms: Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy (2024) Argani P, Gross JM, Baraban E, Rooper LM, Chen S, Lin MT, Gocke C, et al. Journal article Decoil: Reconstructing Extrachromosomal DNA Structural Heterogeneity from Long-Read Sequencing Data (2024) Giurgiu M, Wittstruck N, Rodriguez-Fos E, González RC, Brückner L, Krienelke-Szymansky A, Helmsauer K, et al. Conference contribution A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1 -altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1 - amplified Versus GLI1- rearranged Tumors. (2024) Saoud C, Agaimy A, Dermawan JK, Chen JF, Rosenblum MK, Dickson BC, Dashti N, et al. Journal article Bona fide dendritic cells are pivotal precursors for osteoclasts. (2024) Puchner A, Simader E, Saferding V, Hofmann M, Kieler M, Brunner J, Pfeifle R, et al. Journal article FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity (2024) Agaimy A, Antonescu CR, Bell D, Breimer GE, Dermawan JK, Kester LA, Laco J, et al. Journal article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article Ferroptosis in health and disease. (2024) Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, Bayir H, et al. Journal article, Review article